Intravenous immune globulin in the management of severe Rh D hemolytic disease

Obstetrical and Gynecological Survey

Volumn 52, Issue 3, 1997, Pages 193-197

  Porter, T Flint ^a   Silver, Robert M ^a   Jackson, G Marc ^a   Branch, D Ware ^a   Scott, James R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ALLOIMMUNIZATION; CASE REPORT; FEMALE; FETUS BLOOD SAMPLING; FETUS DISEASE; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY COMPLICATION; REVIEW; RHESUS INCOMPATIBILITY; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADULT; ANTIBODIES; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 0031018572     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199703000-00022     Document Type: Review

References (19)

1. Queenan JT, Tomai TP, Ural SH et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: A proposal for clinical management. Am J Obstet Gynecol 1993; 168:1370.
2. Bowman JM. Hemolytic Disease (Erythroblastosis Fetalis). In: Creasy RK, Resnick R, eds. Maternal-Fetal Medicine. 3rd Ed. Philadelphia: WB Saunders, 1994, pp 711-743.
3. Berlin G, Selbing A, Ryden G. Rhesus hemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1985;1:1153.
4. de la Camara C, Ariieta R, Gonzalez A et al. High dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519-520.
5. Rewald E. Intravenous gamma-globulin to prevent stillbirth in rhesus incompatibility. Lancet 1985;2:208.
6. Margulies M, Voto LS, Mathet ER et al. High-dose intravenous IgG for the treatment of severe rhesus alloimmunization. Vox Sang 1991;61:181-189.
7. Scott JR, Branch DW, Kochenour NK et al. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988;159:1055-1056.
8. Steel CM. Read before you cite. Lancet 1996;348:144.
9. Chitkara U, Bussel J, Alvarez M et al. High-dose intravenous gamma-globulin: Does it have a role in the treatment of severe erythroblastosis fetalis. Obstet Gynecol 1990;76:703-708
10. Ballow M. Mechanisms of action of intravenous immune serum globulin therapy. Pediatr Infect Dis J 1994;13:806-811.
11. NIH Consensus Conference. Intravenous Immunoglobulin: Prevention and treatment of Disease. J Am Med Assoc 1990; 264:3189-3193.
12. Wordell CJ. Use of intravenous immune globulin therapy: an overview. DICP 1991;25:805-817.
13. Sacher RA, King JC. Intravenous gammaglobulin in pregnancy: a review. Obstet Gynecol Surv 1988;44:25-34.
14. Morgan CL, Cannell GR, Addison RS et al. The effect of intravenous immunoglobulin on placental transfer of a platelet-specific antibody: Anti-PIA1. Transfus Med 1991;1:209-216.
15. Lynch L, Bussel JB, McFarland JG et al. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 1992;80: 67-71.
16. Marzusch K, Wiest E, Pfeiffer KH et al. Antenatal fetal therapy for neonatal alloimmune thrombocytopenia with high dose immune globulin. Br J Obstet Gynaecol 1994; 101:1011-1013.
17. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulins. Clin Exp Immunol 1994;97:79-83.
18. ASHP Commission on Therapeutics. ASHP therapeutic guidelines for intravenous immune globulin. Clin Pharmacol Ther 1992;11:117-136.
19. Filbey D, Garner SF, Hadley AG et al. Quantitative and functional assessment of anti-RhD: A comparative study of noninvasive methods in antenatal prediction of Rh hemolytic disease. Acta Obstet Gynecol Scand 1996;75:102-107.